Trial intelligence / Profile preview

Pregabalin and Celecoxib for Function After Total Hip Arthroplasty

NCT00581685Phase 3Completed

Sponsor
Sunnybrook Health Sciences Centre
Start
Jan 2008
Primary completion
Jun 2010
Modality
Orthosteric Ligands
01

Overview

Phase 3, randomised, double-blind trial of pregabalin and celecoxib in osteoarthritis (OA), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Physical function. Started Jan 2008; status: completed.

02

Drugs

pregabalincelecoxib
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00581685.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00581685.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call